Alerts will be sent to your verified email
Verify EmailFISCHER
Fischer Medical
|
Epigral
|
Chemplast Sanmar
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
5.29 % | 23.4 % | -14.92 % |
5yr average Equity Multiplier
|
0.49 | 2.24 | 0.34 |
5yr Average Asset Turnover Ratio
|
0.4 | 0.74 | 0.81 |
5yr Avg Net Profit Margin
|
-4.14 % | 13.76 % | 3.66 % |
Price to Book
|
20.75 | 3.91 | 3.01 |
P/E
|
0.0 | 17.22 | 0.0 |
5yr Avg Cash Conversion Cycle
|
140.14 Days | 22.15 Days | -160.25 Days |
Inventory Days
|
33.45 Days | 32.56 Days | 44.16 Days |
Days Receivable
|
163.11 Days | 27.86 Days | 14.51 Days |
Days Payable
|
23.17 Days | 48.15 Days | 204.35 Days |
5yr Average Interest Coverage Ratio
|
12.88 | 7.91 | 1.57 |
5yr Avg ROCE
|
3.71 % | 23.79 % | 15.83 % |
5yr Avg Operating Profit Margin
|
6.78 % | 29.74 % | 12.16 % |
5 yr average Debt to Equity
|
-0.66 | 0.81 | -0.52 |
5yr CAGR Net Profit
|
n/a | 28.82 % | n/a |
5yr Average Return on Assets
|
-4.27 % | 10.35 % | 3.8 % |
Shareholdings
|
|||
Promoter Holding
|
61.8 % | 68.83 % | 54.99 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
61.8 % | -2.28 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 4.58 % | -0.11 % |
Fischer Medical
|
Epigral
|
Chemplast Sanmar
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|